发明名称 |
A vaccine composition comprising an immunoadjuvant compound consisting of a RHO GTPase family activator |
摘要 |
This invention is based on the experimental finding that activators of Rho GTPases, namely the cytotoxic necrotizing factor 1 (CNF1), and DNT bear immunostimulatory properties towards the systemic response to orally administered ovalbumine. <??>This invention concerns a vaccine composition comprising an immunoadjuvant compound, wherein said immunoadjuvant compound consists of a Rho GTPase activator.
|
申请公布号 |
EP1570856(A2) |
申请公布日期 |
2005.09.07 |
申请号 |
EP20040300100 |
申请日期 |
2004.02.26 |
申请人 |
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) |
发明人 |
LEMICHEZ, EMMANUEL;CZERKINSKY, CECIL;ANJUERRE, FABIENNE;BOQUET, PATRICE;MUNRO, PATRICK;FLATAU, GILLES |
分类号 |
A61K39/39;(IPC1-7):A61K39/108;A61K39/10;A61K39/112;A61K39/106;A61K39/02;A61K39/00 |
主分类号 |
A61K39/39 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|